Noliprel Forte A (Indapamide, Perindopril Arginine)

Indapamide and Perindopril arginine, the active ingredients in Noliprel Forte A, are a thiazide‑like diuretic and an ACE inhibitor presented as an oral tablet for oral use. The combination is employed to lower elevated blood pressure in adult patients with hypertension. It is indicated for patients who require combined antihypertensive therapy to achieve target blood pressure levels.

GNH USA supplies Noliprel Forte A as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Noliprel Forte A is used in the management of hypertension, a condition characterized by chronically elevated arterial pressure.

Hypertension: reduces systolic and diastolic blood pressure, helping achieve guideline‑recommended targets. High cardiovascular risk patients: lowers risk of stroke and myocardial infarction when combined with lifestyle measures. Isolated systolic hypertension in elderly: provides effective blood pressure control with a favorable tolerability profile.

Adverse reactions reported with Noliprel Forte A are categorized by frequency.

Common Side Effects: - Dizziness or light‑headedness. - Persistent dry cough. - Headache. - Increased urinary frequency or volume.

Serious or Rare Side Effects: - Angioedema involving face, lips, tongue or airway. - Severe hypotension leading to fainting. - Acute renal impairment or failure.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor relevant parameters.

Renal function: assess baseline creatinine and monitor periodically. Electrolyte balance: check serum potassium and sodium levels during therapy. Pregnancy and lactation: avoid unless benefits outweigh risks, as safety data are limited. Concomitant ACE inhibitors or ARBs: increase risk of hyperkalemia and renal dysfunction. Dehydration or volume depletion: ensure adequate fluid intake to prevent orthostatic symptoms. Store at ambient temperature: keep in original container, protect from moisture and light.

Noliprel Forte A may interact with several medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone) – risk of hyperkalemia. - Aliskiren combined with ACE inhibitors – increased renal adverse events. - Lithium – increased lithium levels and toxicity. - NSAIDs – may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Thiazide diuretics – additive diuretic effect, monitor electrolytes. - Beta‑blockers – may enhance blood pressure lowering, watch for bradycardia. - Antihypertensive combinations – dose adjustments may be needed to avoid excessive hypotension.